Over April, we continued to learn more about psychedelic medicine. Researchers argued that psilocybin increases global integration in the depressed brain and that classic psychedelic use is associated with lower odds of opioid use disorders. In other exciting papers, the role of therapy and therapists themselves in psychedelic therapy was further explored. While April may not have brought as many…
